Biography

Dr. Janice Kwon obtained her medical degree and Obstetrics and Gynecology training at Queen’s University.  She completed her fellowship training in Gynecologic Oncology in Toronto, followed by a Masters degree in Public Health from Harvard.  She had a 2-year appointment at the University of Texas M.D. Anderson Cancer Center in Houston, Texas prior to her appointment at UBC.

Dr. Kwon is currently the Director of the Gynecologic Oncology fellowship training program and the co-Chair of the Resident Research Advisory Committee for the Department of Obstetrics and Gynecology at UBC.  She is on the Executive of the Gynecology Disease Site group of the National Cancer Institute of Canada.

Dr. Kwon’s major areas of research interest are in health policy relating to gynecologic cancers as well as hereditary cancer syndromes.  She has conducted population-based studies of endometrial and ovarian cancers and cost-effectiveness analyses of testing criteria and risk-reducing strategies for women at risk for genetic mutations.  Her teaching commitments include undergraduate and postgraduate levels and the Family Practice Oncology Network.

Publications

Kwon JS, Tinker A, Pansegrau G, McAlpine J, Housty M, McCullum M, Gilks CB.  “Prophylactic salpingectomy followed by delayed oophorectomy for BRCA mutation carriers”.  Obstet Gynecol 2013;12:14-24

Longpre MJ, Lange PH, Kwon JS, Black PC. “Penile carcinoma:  Lessons learned from vulvar carcinoma”.  J Urol 2013;189:17-24

Dehaeck U, McGahan C, Santos J, Carey M, Swenerton K, Kwon JS.  “The impact of geographic variation in treatment on ovarian cancer outcomes”.  Int J Gynecol Cancer 2013;23:282-87

Krueger H, Kwon J, Sadownik L, Ogilvie G, Elwood Martin R. “What is the most appropriate age to start screening for cervical cancer?”  BCMJ 2013;55(6):244-48.

Lee M, Aquino-Parsons C, Lim P, Hoskins P, Kwon JS.  “Preoperative radiotherapy for Stage II endometrial cancer:  Insights into improving treatment and outcomes”.  J Obstet Gynecol Can 2013;35(7):635-9

 O’Cathail SM, Shaboodien R, Mahmood S, Carty K, O’Sullivan P, Blagden S, Gabra H, Whear S, Kwon JS, Agarwal R.  “Intravenous versus oral dexamethasone premedication in preventing paclitaxel infusion hypersensitivity reactions in gynecological malignancies”.  Int J Gynecol Cancer 2013 Sep;23(7):1318-25

 Giede C, Le T, Power P, Bentley J, Farrell S, Fortier MP, Giede C, Kupets R, Plante M, Power P, Renaud MC, Schepansky A, Senikas V, Kwon J, Préfontaine M, Germain I, Pearcey R, D’Souza D, Senterman M, Hoskins P; SOGC-GOC-SCC Policy and Practice Guideline Committee. “The role of surgery in endometrial cancer”. J Obstet Gynaecol Can 2013 Apr;35(4):370-4

 Kupets R, Le T, Bentley J, Farrell S, Fortier MP, Giede C, Kupets R, Plante M, Power P, Renaud MC, Schepansky A, Senikas V, Kwon J, Préfontaine M, Germain I, Pearcey R, D’Souza D, Senterman M, Hoskins P; SOGC-GOC-SCC Policy and Practice Guidelines Committee. “The role of adjuvant therapy in endometrial cancer”. J Obstet Gynaecol Can 2013 Apr;35(4):375-9

 Renaud MC, Le T, Bentley J, Farrell S, Fortier MP, Giede C, Kupets R, Plante M, Power P, Renaud MC, Schepansky A, Senikas V, Kwon J, Préfontaine M, Germain I, Pearcey R, D’Souza D, Senterman M, Hoskins P; SOGC-GOC-SCC Policy and Practice Guidelines Committee. “Epidemiology and investigations for suspected endometrial cancer”. J Obstet Gynaecol Can 2013 Apr;35(4):380-3

Jutzi L, Hoskins P, Lim P, Aquino-Parsons C, Tinker A, Kwon JS.  “The importance of adjuvant chemotherapy and pelvic radiotherapy in high-risk early stage endometrial carcinoma”.  Gynecol Oncol 2013;131:581-585

Schefter T, Winter K, Kwon JS, Stuhr K, Balaraj K, Yaremko BP, Small W Jr, Sause W, Gaffney D.  “RTOG 0417: Efficacy of Bevacizumab in combination with definitive radiation therapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma”.  Int J Radiation Oncol Biol Phys 2014;88(1):101-105

Van der Putten LJM, Hoskins P, Tinker A, Lim A, Aquino-Parsons C, Kwon JS.  “Population-based treatment and outcomes of Stage I uterine serous carcinoma”.  Gynecol Oncol 2014;132:261-64

 Kwon JS, McGahan C, Dehaeck U, Santos J, Swenerton K, Carey MS.  “The significance of combination chemotherapy in epithelial ovarian cancer”.  Int J Gynecol Cancer 2014;24(2):226-32

Jutzi L, Russell D, Ho S, Kwon JS.  “The role of palliative colorectal stents in gynecologic malignancies”.  Gynecol Oncol 2014;134(3):566-9

Eghdami L, Kwon JS.  “Peritoneal tuberculosis presenting as persistent ascites”.  J Obstet Gynecol Can 2014.  In press.

Grants

CIHR
Randomized trial comparing radical hysterectomy with simple hysterectomy in early cervical cancer
PI: Ralph Meyer, Marie Plante. Co-investigators: Anthony Fyles, Peter Craighead, Lori Brotto, Michael Brundage, Sarah Ferguson, Nicole Mittman, Jocelyne Arseneau, Mostafa Atri, Dongsheng Tu, Janice Kwon, Gavin Stuart

Ovarian Cancer SPORE (Specialized Program of Research Excellence), NCI
Project 1: Early detection of epithelial ovarian cancer (substudy: Cost-effectiveness analysis of ROCA)
PI: Robert C. Bast, Jr, Karen Lu. Co-investigator: Janice Kwon

British Columbia Cancer Foundation
“Diabetic pharmacotherapy and endometrial cancer risk”
PI: Janice Kwon; co-investigators Arianne Albert, Sabrina Gill